Evidence map›Paper›PMID 32661834›Full record

ReviewGeneral thoracic and cardiovascular surgery2020

Sentinel lymph node biopsy for lung cancer.

Alexander Gregor, Hideki Ujiie, Kazuhiro Yasufuku

Abstract readReview
PubMed Publisher
In one paragraph

Review in General thoracic and cardiovascular surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Journal of thoracic disease · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Assessment of Updated Commission on Cancer Guidelines for Intraoperative Lymph Node Sampling in Early Stage NSCLC.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Alexander GregorDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.
Hideki UjiieDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada. Hideki.Ujiie.MD@gmail.com.ORCID http://orcid.org/0000-0001-6119-8776
Kazuhiro YasufukuDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.
University Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sentinel lymph node biopsy is a technique to identify the first lymph node (or nodes) draining a tumor. The underlying principle is that as the first site of cancer spread, evaluation of the sentinel node will be most predictive for wider nodal involvement. The introduction of sentinel node biopsy revolutionized the surgical management of cutaneous melanoma and breast cancer, becoming a key component in the management of such patients. For over 20 years, thoracic surgeons have similarly worked to apply this technique to lung cancer but have thus far not had the same impact on lung surgery. In this review, we will summarize the ongoing discussions on the role of sentinel node biopsy in lung cancer, the methods for identifying the sentinel node, and the techniques for evaluating the sentinel node specimen. We will also highlight some of the pressing questions investigators should consider when designing a trial for sentinel node mapping. This will clarify the current status of sentinel node biopsy in lung cancer and thus highlight important future directions for research.

Indexed as

Carcinoma, Non-Small-Cell LungHumansLung NeoplasmsLymphatic MetastasisRadioactive TracersSentinel Lymph NodeSentinel Lymph Node BiopsyRadioactive TracersIndocyanine green (ICG)Near-infrared (NIR)Non-small cell lung cancer (NSCLC)Sentinel lymph node (SLN)

Identifiers

PMID32661834
OpenAlexW3041611398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.